Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 22712157)

1.

Parkinson disease.

Park NH.

JAAPA. 2012 May;25(5):73-4. Review. No abstract available.

PMID:
22712157
2.

[Genetics and present therapy options in Parkinson's disease: a review].

Bereznai B, Molnar MJ.

Ideggyogy Sz. 2009 May 30;62(5-6):155-63. Review. Hungarian.

PMID:
19579663
3.

The genetics of Parkinson disease: to test or not to test.

Suchowersky O.

Can J Neurol Sci. 2007 Aug;34(3):266-7. No abstract available.

PMID:
17803021
4.

PD or not PD? That is the question.

Tanner CM.

Neurology. 2003 Jul 8;61(1):5-6. No abstract available.

PMID:
12847146
5.

Genetic testing in Parkinson disease: promises and pitfalls.

Tan EK, Jankovic J.

Arch Neurol. 2006 Sep;63(9):1232-7. Review. No abstract available.

PMID:
16966499
6.

Different saccadic abnormalities in PINK1 mutation carriers and in patients with non-genetic Parkinson's disease.

Hertel S, Sprenger A, Klein C, Kömpf D, Helmchen C, Kimmig H.

J Neurol. 2009 Jul;256(7):1192-4. doi: 10.1007/s00415-009-5092-8. Epub 2009 Mar 29. No abstract available.

PMID:
19330279
7.

Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes.

Crosiers D, Theuns J, Cras P, Van Broeckhoven C.

J Chem Neuroanat. 2011 Oct;42(2):131-41. doi: 10.1016/j.jchemneu.2011.07.003. Epub 2011 Jul 26. Review.

PMID:
21810464
8.

[Hereditary Parkinson disease. The Danish Society of Movement Disorders].

Hjermind LE, Nielsen JE; Dansk Selskab for Bevaegeforstyrrelser.

Ugeskr Laeger. 2008 Mar 17;170(12):1016. Danish. No abstract available.

PMID:
18397634
9.

LRRK2: both a cause and a risk factor for Parkinson disease?

Foroud T.

Neurology. 2005 Sep 13;65(5):664-5. No abstract available.

PMID:
16157895
10.

[Utility of new tools in the diagnosis of Parkinson's disease: need for regulation].

Linazasoro G.

Neurologia. 2005 Jul-Aug;20(6):323-5. Spanish. No abstract available.

PMID:
16007518
11.

Parkinson disease: genetic testing in Parkinson disease-who should be assessed?

Klein C, Djarmati A.

Nat Rev Neurol. 2011 Jan;7(1):7-9. doi: 10.1038/nrneurol.2010.197. No abstract available.

PMID:
21221111
12.

Translating genetic findings into therapy in Parkinson disease.

Palomo SM, Jimenez-Escrig A.

Recent Pat CNS Drug Discov. 2007 Nov;2(3):229-37. Review.

PMID:
18221233
13.
14.

From GWAS to clinical utility in Parkinson's disease.

Klein C, Ziegler A.

Lancet. 2011 Feb 19;377(9766):613-4. doi: 10.1016/S0140-6736(11)60062-7. Epub 2011 Feb 1. No abstract available.

PMID:
21292316
15.

[Parkinson disease. Etiology, physiopathology, diagnosis, development, treatment].

Fénelon G.

Rev Prat. 1996 Nov 1;46(17):2137-44. French. No abstract available.

PMID:
8978170
16.

Parkinson disease(s): is "Parkin disease" a distinct clinical entity?

Klein C, Lohmann K.

Neurology. 2009 Jan 13;72(2):106-7. doi: 10.1212/01.wnl.0000333666.65522.8d. Epub 2008 Nov 5. No abstract available.

PMID:
18987349
18.

Association of pyridoxal kinase and Parkinson disease.

Vilariño-Güell C, Wider C, Aasly JO, White LR, Rajput A, Rajput AH, Lynch T, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Ann Neurol. 2010 Mar;67(3):409-11. doi: 10.1002/ana.21962. No abstract available.

PMID:
20373354
19.

The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany.

Schlitter AM, Woitalla D, Mueller T, Epplen JT, Dekomien G.

J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):891-2. No abstract available.

20.

POLG1 in idiopathic Parkinson disease.

Tiangyou W, Hudson G, Ghezzi D, Ferrari G, Zeviani M, Burn DJ, Chinnery PF.

Neurology. 2006 Nov 14;67(9):1698-700. Epub 2006 Aug 30.

PMID:
16943369
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk